We are live on
!
Find out more
IAM
Innovis Asset Management Portfolio holdings
AUM
$260M
1-Year Est. Return
28.13%
This Fund
S&P 500
This Quarter
Est. Return
+8.36%
1 Year Est. Return
+28.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$247M
AUM Growth
+$25.2M
(+11%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
33.44%
Holding
176
New
26
Increased
78
Reduced
42
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$5.43M |
| 2 |
Freeport-McMoran
FCX
|
+$3.38M |
| 3 |
Performance Food Group
PFGC
|
+$3.16M |
| 4 |
Enphase Energy
ENPH
|
+$2.74M |
| 5 |
Emerson Electric
EMR
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.88M |
| 2 |
Advanced Micro Devices
AMD
|
+$1.7M |
| 3 |
Palo Alto Networks
PANW
|
+$1.35M |
| 4 |
P
Everpure Inc
P
|
+$1.21M |
| 5 |
Visa
V
|
+$1.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.58% |
| 2 | Healthcare | 22.06% |
| 3 | Financials | 9.69% |
| 4 | Energy | 8.61% |
| 5 | Consumer Staples | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Tarsus Pharmaceuticals
TARS
$2.84B
| $164K | 0.07% |
13,059
+78
| +0.6% | +$1.14K |
|
152
Trevi Therapeutics
TRVI
$2.64B
| $162K | 0.07% |
87,369
-84
| -0.1% | -$190 |
|
153
Iovance Biotherapeutics
IOVA
$2.87B
| $161K | 0.07% |
26,384
-14,598
| -36% | -$101K |
|
154
A10 Networks
ATEN
$1.95B
| $161K | 0.07% |
10,404
+44
| +0.4% | +$671 |
|
155
Geron
GERN
$949M
| $135K | 0.05% |
+62,414
| New | +$177K |
|
156
Erasca
ERAS
$6.39B
| $131K | 0.05% |
43,437
+21,081
| +94% | +$76.7K |
|
157
Immunic
IMUX
$195M
| $120K | 0.05% |
+8,077
| New | +$150K |
|
158
Aspen Aerogels
ASPN
$518M
| $107K | 0.04% |
14,413
+62
| +0.4% | +$616 |
|
|
AIOT
159
PowerFleet Inc
AIOT
$592M
| $101K | 0.04% |
+29,416
| New | +$82.2K |
|
160
Motorcar Parts of America
MPAA
$258M
| $96.9K | 0.04% |
13,018
-42,053
| -76% | -$501K |
|
|
GBIO
161
DELISTED
Generation Bio
GBIO
| $85.5K | 0.03% |
1,988
-19
| -0.9% | -$919 |
|
|
CADE
162
DELISTED
Cadence Bank
CADE
| – | – |
-8,161
| Closed | -$201K |
|
163
Cerus
CERS
$474M
| – | – |
-91,824
| Closed | -$335K |
|
164
Cytek Biosciences
CTKB
$546M
| – | – |
-14,565
| Closed | -$149K |
|
165
Dime Commercial Bancshares
DCOM
$1.78B
| – | – |
-10,428
| Closed | -$332K |
|
166
Enovix
ENVX
$1.03B
| – | – |
-24,649
| Closed | -$268K |
|
167
First Financial Bankshares
FFIN
$4.97B
| – | – |
-8,640
| Closed | -$297K |
|
|
HBI
168
DELISTED
Hanesbrands
HBI
| – | – |
-112,824
| Closed | -$718K |
|
|
SFIX
169
Stitch Fix
SFIX
$560M
| – | – |
-180,069
| Closed | -$560K |
|
170
STAG Industrial
STAG
$7.19B
| – | – |
-12,194
| Closed | -$394K |
|
171
Southwest Gas
SWX
$6.67B
| – | – |
-6,457
| Closed | -$400K |
|
|
ITCI
172
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-10,588
| Closed | -$560K |
|
|
AAN
173
DELISTED
The Aaron's Company Inc
AAN
| – | – |
-27,025
| Closed | -$323K |
|
|
SIX
174
DELISTED
Six Flags Entertainment Corp.
SIX
| – | – |
-15,287
| Closed | -$355K |
|
|
LIAN
175
DELISTED
LianBio American Depositary Shares
LIAN
| – | – |
-176,192
| Closed | -$289K |
|
Similar funds
RCGI
RBGI
AEPLI
PWM
T
SC
CA
W
Innovis Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Innovis Asset Management held 176 positions worth $247M, up 11% from $221M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Innovis Asset Management deployed $12.2M of net new capital in Q1 2023, opening 26 new positions and adding to 78 existing holdings. Its largest new stake was Newmont: 112,058 shares worth $5.49M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $2.88M trimmed.
- Innovis Asset Management's largest Q1 2023 buy was Newmont: 112,058 shares worth $5.49M.
- Innovis Asset Management added most to Enphase Energy in Q1 2023, an estimated $2.74M increase.
- Innovis Asset Management's biggest Q1 2023 reduction was NVIDIA, cutting an estimated $2.88M.
- Innovis Asset Management fully exited Hanesbrands in Q1 2023, selling an estimated $718K.
- Innovis Asset Management's ten largest holdings make up 33% of its $247M portfolio in Q1 2023.
- Innovis Asset Management opened 26 new positions and closed 15 in Q1 2023.
- Innovis Asset Management's portfolio value rose 11% quarter-over-quarter to $247M.
Based on Innovis Asset Management's 13F filing for Q1 2023, filed 10 May 2023.